Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
sales@dingminpharma.com
86-311-67260775
Productos
Descripción
Detalles de producto
SELEXIPAG de alta calidad CAS intermedio no . 243472-70-0 :
Cas no.: 243472-70-0
Nombre: SelExIPag Intermediate
Apariencia: polvo blanco de blanco a blanco
Pureza: 99%+
SelExIPag (marca uptravi) es un fármaco desarrollado por Actelion para el tratamiento de la hipertensión arterial pulmonar (HAP). Selexipag y su metabolito activo, ACT-3333679 (o MRE-269, el ácido carboxílico libre), son agonistas del receptor de prostaciclina, lo que conduce a la vasodilatación en la circulación pulmonar.
Somos el fabricante de API, farmacéutica de materia prima, intermedios farmacéuticos, ingredientes farmacéuticos activos, intermedios agroquímicos y productos químicos finos.
YOU MIGHT ALSO LIKE
Ponerse en contacto
If you have any questions our products or services,feel free to reach out to us.Provide unique experiences for everyone involved with a brand. we’ve got preferential price and best-quality products for you.
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.